Clinical trial
Long-Term Supervised Treatment Interruption in HIV-Infected Patients
NCT00118677 · French National Agency for Research on AIDS and Viral Hepatitis, Other · Completed
Key facts
| NCT number | NCT00118677 |
|---|---|
| Title | Long-Term Supervised Treatment Interruption in HIV-Infected Patients |
| Official title | Long-Term Supervised Treatment Interruption in HIV-Infected Patients Who Started Antiretroviral Treatment With CD4 Over 350/mm3 and Plasma HIV RNA Below 50 000/mL ANRS 116 Trial SALTO |
| Lead sponsor | French National Agency for Research on AIDS and Viral Hepatitis, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Procedure |
| Interventions | Treatment interruption |
| Enrollment | 130 |
| Start date | Feb 1, 2003 |
| Completion | May 1, 2007 |
| First posted | Jul 12, 2005 |
| Last update posted | Aug 30, 2007 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: